Leaderboard

En | De
Sie sind hier: Respirationstrakt » Neoplasie 21. August 2026
Suchen
medline.ch
Neoplasie
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Allergische Rhinitis - Pollinosis
Asthma
Bronchitis
COPD
Interstitielle Pneumopathien
Lungenembolie
Neoplasie
Pleuraerkrankungen
Pneumonie
SARS
Schlaf- Apnoe-Syndrom
Tuberkulose
Zystische Fibrose
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 8122  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 162430  
   
Lung Cancer Screening Access and Cancer Stage at Diagnosis Among American Indian and White Patients.
J Rural Health
Jackson BE, Uhrin M, Wheeler SB, Baggett CD, Spees LP, Begay JA, Bell RA, Emerson MA.
PMID: 42627130 [PubMed - indexed for MEDLINE]


Efficacy and safety of almonertinib as adjuvant therapy in stage II-IIIA EGFR-mutant non-small cell lung cancer: a retrospective study.
Front Med (Lausanne)
Cao T, Chen L, Li Y, Wu S, Liu Y, Tian W, Zhang Y, An Y, Wang M, Lu Z, Wang Q.
PMID: 42625890 [PubMed]


Implementation of a lung cancer screening program at an urban safety-net hospital: enabling solutions via stakeholder engagement.
Front Public Health
Kuperberg SJ, Mercado J.
PMID: 42625749 [PubMed - indexed for MEDLINE]


The relationship between sarcopenia detected in newly diagnosed lung cancer patients and serum levels of IL6, IGF-1 and myostatin.
Front Aging
Süzer K, Oflazoglu U, Demir L, Unal S, Guc ZG, Yildiz Y, Karalar FO, Kucukzeybek Y, Alacacioglu A.
PMID: 42625663 [PubMed]


An integrated multimodal model for early prediction of high-risk recurrence phenotype indicative of poor disease-free survival in stage IA NSCLC: a multicenter study.
Front Immunol
Lai L, Wang Y, Jiang J, Yang D, Wu J, Xie L, Wu J, Mao R, Zhang D, Wang X, Ming W, Tu J.
PMID: 42625643 [PubMed - indexed for MEDLINE]


Assessment of risk factors in persistent subsolid pulmonary nodules based on CT dynamic follow-up.
BMC Med Imaging
Li F, Liu J, Ren X, Chen Z, Yang S, Ma Y, Li Y, Du Y, Yang X.
PMID: 42625155 [PubMed - indexed for MEDLINE]


Diagnostic Performance of a Multiplex Circulating Tumor DNA Assay for Lung Cancer Detection.
J Mol Diagn
Hjorth-Hansen P, Jacobsen CM, Nederby L, Borg M, Hilberg O, Wen SWC, Timm S, Hansen TF, Andersen RF.
PMID: 42624248 [PubMed - as supplied by publisher]


Lung cancer mortality of workers occupationally exposed to titanium dioxide in Germany: new insights from a retrospective cohort study after accounting for smoking status.
Int J Hyg Environ Health
Jannis H, Hiltrud M, Ingo L, Maria B, Stefanie J K, Emilio G.
PMID: 42624005 [PubMed - as supplied by publisher]


Spatially Fractionated Induction Radiotherapy to Widen the Therapeutic Window in Locally Advanced Non-Small-Cell Lung Cancer (SPARROW): Study Protocol of a Multicenter, Randomized, Open-Label Seamless Phase I/II Trial.
Clin Lung Cancer
Regnery S, Ehle M, Neugebauer D, Gerke L, Schindehütte R, Bauer L, Mende S, Kirchner M, Balzer A, Gahlawat A, Abdollahi A, Kazdal D, Stenzinger A, Hörner-Rieber J, Uhl M, Aninditha K, Münter M, Welzel T, Debus J, Weykamp F.
PMID: 42623891 [PubMed - as supplied by publisher]


Association between rheumatoid arthritis-interstitial lung disease and lung cancer: a two -sample Mendelian randomization study with East Asian genetic instruments.
Mod Rheumatol
Hsu CH, Chen SC, Yu YL.
PMID: 42623285 [PubMed - as supplied by publisher]


Increasing lung cancer screening referral/order and completion rates in primary care through patient outreach and shared decision making.
J Med Screen
DiCarlo M, Shimada A, Sifri R, Johnson M, Keith SW, Zhan T, Jackson H, Indictor A, Burgess N, Mahon I, Pisano E, Myers RE.
PMID: 42623060 [PubMed - as supplied by publisher]


KRAS-Targeted Therapies in NSCLC: Resistance, Combination Strategies, and Emerging Clinical Paradigms.
Med Oncol
Kapoor A, Sansar B, Gupta A, Mishra BK, Rungta A, Pal A, Srivastava S, Shah M, Menon N, Pai T, Shetty O, Chandrani P, Choughule A, Noronha V, Prabhash K.
PMID: 42622884 [PubMed - indexed for MEDLINE]


Efficacy and safety of different treatment regimens in patients with small cell lung cancer progressing from limited-stage to extensive-stage disease.
Ther Adv Med Oncol
Yu M, Liu Y, Wang X, Cui W, Sun F, Li Y, Zhao K, Zhao H, Meng X.
PMID: 42621307 [PubMed]


Prospective subtyping identifies an association between high pretreatment levels of DEspR(+) neutrophil extracellular trap-forming neutrophils and microvesicles during sterile inflammation with poor survival in patients with metastatic non-small cell lung cancer receiving first-line combination chemo-immunotherapy.
Front Immunol
Herrera VLM, Mahdaviani K, Choi J, Chen SH, Gunn E, Stadnicki K, Mortazavi-Zadeh A, Lok JJ, Tapan U, Ruiz-Opazo N.
PMID: 42620556 [PubMed - indexed for MEDLINE]


Update 2026: Management of Small Cell Lung Cancer.
Lung
Lalla M, Dhillon P, Polat BE, Cheng H.
PMID: 42618851 [PubMed - indexed for MEDLINE]


Automated identification of interstitial lung abnormalities in lung screening using quantitative CT.
BMJ Open Respir Res
Logan N, Desai SR, Bartlett EC, Hewitt R, George PM, Devaraj A.
PMID: 42618282 [PubMed - indexed for MEDLINE]


Increasing uptake of lung cancer screening through a patient 'nudge': A randomized pragmatic trial.
Am J Prev Med
Carroll NM, Maclennan AJ, Wain KF, Hixon B, Steiner J, Ritzwoller DP.
PMID: 42617889 [PubMed - as supplied by publisher]


Gold Nanostars: Emerging Plasmonic Nanoplatforms for Lung Cancer Diagnosis and Therapy.
Eur J Pharm Sci
Rawat E, Ali AA, Kumar M, Uniyal P, Haswani NG, Bhongade BA, El-Tanani M, Thakkar V, Kapoor DU.
PMID: 42617669 [PubMed - as supplied by publisher]


What matters most early in the cancer trajectory: patient concerns and priorities in pancreatic and lung cancer (BetterEveryDay trial).
Eur J Oncol Nurs
Mikkelsen MK, Rolin L, Theile S, Markman MJN, Hald C, Chen IM.
PMID: 42617508 [PubMed - as supplied by publisher]


Experience of the implementation of a lung cancer screening program at the Hospital General de Catalunya (Barcelona, Spain).
Curr Probl Cancer
Moya-Horno I, González-Marrón A, Barcos-Muñoz P, Abad S, Molina-Vila MÁ, Torres-Martí A, González X, Mayolas N, Rosell R.
PMID: 42617374 [PubMed - as supplied by publisher]


   
   Artikel 1 - 20 / 162430    Seite 1 von 8122  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

  Zeitfenster  
   

Sky right 1